Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000315066-18-000081
Filing Date
2018-01-24
Accepted
2018-01-24 19:45:28
Documents
1
Period of Report
2018-01-24

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 6683
  Complete submission text file 0000315066-18-000081.txt   8371
Mailing Address 245 SUMMER STREET BOSTON MA 02210
Business Address 245 SUMMER STREET BOSTON MA 02210 6175706339
FMR LLC (Reporting) CIK: 0000315066 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38356 | Film No.: 18546414

Mailing Address 4085 CAMPBELL AVENUE, SUITE 200 MENLO PARK CA 94025
Business Address 4085 CAMPBELL AVENUE, SUITE 200 MENLO PARK CA 94025 650-486-1416
Menlo Therapeutics, Inc. (Issuer) CIK: 0001566044 (see all company filings)

EIN.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations